GT Biopharma, Inc. (GTBP) DCF Valuation

GT Biopharma, Inc. (GTBP) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

GT Biopharma, Inc. (GTBP) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify GT Biopharma, Inc. (GTBP) valuation with this customizable DCF Calculator! Featuring real GT Biopharma, Inc. (GTBP) financials and adjustable forecast inputs, you can test scenarios and uncover GT Biopharma, Inc. (GTBP) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -11.5 -25.0 .0 .0 6.0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 57.5 21.3 13.6 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -11.5 -25.0 -57.5 -21.3 -7.6 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .0 5.3 32.0 16.5 14.0 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.9 2.2 8.2 3.1 4.3 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -12.1 -27.9 -58.2 -20.9 -7.6 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -10.1 -27.6 5.3 -4.7 7.2 -4.3 .0 .0 .0 .0
WACC, % 7.1 7.1 7.1 7.1 7.1 7.1 7.1 7.1 7.1 7.1
PV UFCF
SUM PV UFCF -4.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -4
Net Debt -1
Equity Value -3
Diluted Shares Outstanding, MM 1
Equity Value Per Share -2.24

What You Will Receive

  • Adjustable Forecast Parameters: Seamlessly modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Comprehensive Data: GT Biopharma, Inc.'s (GTBP) financial data pre-loaded to facilitate your analysis.
  • Automated DCF Calculations: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Tailored and Professional Design: A refined Excel model that meets your valuation requirements.
  • Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Comprehensive GTBP Financials: Gain access to reliable pre-loaded historical data and future forecasts.
  • Tailored Forecast Assumptions: Modify highlighted cells for key metrics like WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Clear charts and summaries to help you visualize valuation outcomes.
  • Designed for All Skill Levels: A straightforward, intuitive layout suitable for investors, CFOs, and consultants.

How It Works

  • 1. Access the Template: Download and open the Excel file containing GT Biopharma, Inc. (GTBP)'s preloaded data.
  • 2. Modify Assumptions: Adjust critical inputs such as growth rates, WACC, and capital expenditures.
  • 3. Analyze Results Instantly: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Scenarios: Evaluate various forecasts to investigate different valuation possibilities.
  • 5. Present with Assurance: Deliver professional valuation insights to enhance your decision-making.

Why Choose This Calculator for GT Biopharma, Inc. (GTBP)?

  • Accuracy: Utilizes real GT Biopharma financials to ensure precise data.
  • Flexibility: Tailored for users to experiment and adjust inputs as needed.
  • Time-Saving: Eliminate the need to construct a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
  • User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling GT Biopharma, Inc. (GTBP) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for GT Biopharma, Inc. (GTBP).
  • Consultants: Deliver professional valuation insights on GT Biopharma, Inc. (GTBP) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like GT Biopharma, Inc. (GTBP) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to GT Biopharma, Inc. (GTBP).

What the Template Contains

  • Pre-Filled Data: Includes GT Biopharma’s historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze GT Biopharma’s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.